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Introduction
At present, there is great concern with regard to malignant neoplasms, which are commonly known as cancer, being one of the leading causes of death worldwide. Various cancer therapies exist, such as surgery, chemotherapy, radiation therapy as well as individually applied methods like biological therapy, hormone therapy and photodynamic therapy.
1 New techniques showing promises and directly related to the focus of this work, is the development of theranostic systems that combine therapeutic, targeting and diagnostic agents on a single platform. Due to the ability to perfuse out of the bloodstream easily and the high tissue permeability, theranostic nanoparticle (NP) systems may be able to provide a high imaging sensitivity, precise targeting and a controlled drug release.
2 Typically, drug conjugates or complexes are used which combine the therapeutic effect of an anticancer drug with the ability of metal(oxide) NPs to be utilized for real-time imaging of the tumor. For instance, the combination of magnetite NPs which provide a contrast enhancement in magnetic resonance imaging, a self-assembled layer of (3-aminopropyl)trimethoxysilane (APTMS) and methotrexate (MTX) as a chemotherapeutic drug was shown to be selective in binding to tumor cells. [3] [4] [5] MTX can target cancer cells whose surfaces are overexpressed by folate receptors and is one of the most widely applied drugs for the treatment of cancer in its various forms, such as breast cancer, head and neck cancer and carcinomas. 3, 6, 7 Over the past several years, significant effort has been made to change the pharmacokinetic behaviour of MTX by linking it to macromolecular carrier systems. For instance, by conjugating MTX to microparticles that were made of gelatin or polyglutaraldehyde, the controlled drug release could be improved. 8, 9 Another promising cancer treatment is based on radiation therapy. To enhance the radiosensitivity of the tumor in addition to the radiation beam, high atomic number (Z) materials such as gold or platinum NPs are introduced into cancer cells. [10] [11] [12] [13] [14] Brown et al. provided a dose enhancement radiation on cancer cells by using tantalum pentoxide as radiosensitiser. 15 Bismuth is the element with the highest atomic number (Z=83) that is reasonably cheap, available in great amounts and above all, biocompatible. 16 Dependent on the synthesis method, bismuth oxide can scavenge reactive oxygen species (ROS) resulting in an increased proliferation of cells or generate ROS what in turn yields in a high cancer cell death rate. 16 Therefore, bismuth compounds may be even more promising materials for dose enhancement radiotherapy compared with tantalum pentoxide. Bismuth compounds, such as bismuth subsalicylate and bismuth oxychloride are used in medicine or cosmetics, respectively. [17] [18] [19] [20] Coated, non-single phase bismuth oxide NPs were investigated for biomedical application such as a contrast agent for X-ray imaging or in endodontic treatment. 21, 22 Due to the adjustable cytotoxicity of bismuth oxide, 16 the high effective Z and the ability to provide real-time imaging and dose enhancement, bismuth oxide NPs are a promising candidate for a theranostic system.
Our goal is to successfully combine a targeted chemotherapeutic treatment with diagnostic imaging capabilities based on computer tomography (CT) and an effective radiation cancer therapy using the high effective Z of employed ceramic NPs. For the first time, we report the synthesis and characterisation of single phase bismuth oxide NPs that were linked with MTX through APTMS ( Fig.   1 ) in the form of a core-shell structure. MTX can be released from the linker by a cleavage of the amide bond at low pH in the presence of lysosomes which are typically found inside target cells.
Since target cells provide a higher number of folate receptors in contrast to healthy cells, intoxication of latter ones can be reduced. 
Experimental

Materials
The chemicals used include bismuth (III) nitrate pentahydrate (≥98%), ammonium hydroxide (28-30%), (3-aminopropyl) 
Synthesis of α-Bi 2 O 3 Nanoparticles via Precipitation
The bismuth oxide nanoparticles (NPs) were synthesised from bismuth nitrate using the methodology outlined in the article published by M.M. Patil et al. 23 The amorphous precipitate was annealed in air in order to obtain bismuth oxide with an increased cancer cell death rate. 16 
X-Ray Diffraction (XRD)
Crystalline structures were investigated using an Enhanced Mini-Materials Analyzer (EMMA) X-Ray
Diffractometer from GBC Scientific. The measurements were carried out at room temperature with Cu K-alpha radiation (λ=1.5418 Å) at 40 kV and 25 mA in the range of 20 to 80° at 2.00°/min with a step size of 0.02°. The mean crystalline size was determined using the Scherrer equation, where d is the average crystallite size, K is a constant (assuming that the particles are spherical, K=0.89), λ is the wavelength of the X-ray radiation, β is the full width at half maximum and θ is the Bragg angle of diffraction:
The lattice parameters were obtained via Rietveld refinement using the Marquardt least square method.
Fourier Transform Infrared (FTIR) Spectroscopy
Fourier transform infrared spectra were recorded on an IR Prestige 21 spectrometer from Shimadzu Corporation (Kyoto, Japan) over the range of 4000 to 600 cm -1 via attenuated total reflectance (MIRacle).
Ultraviolet-visible (UV-Vis) Spectroscopy
The absorbance was recorded on an UV-3600 spectrophotometer from Shimadzu Corporation (Kyoto, Japan) over the range of 800 to 200 nm by using quartz cuvettes. The unknown concentration of MTX was determined via a calibration curve using the Lambert-Beer law, where A is the absorbance, c is the concentration of the compound in solution, ε is the extinction coefficient and l is the path length of the sample:
Scanning Electron Microscopy (SEM), Scanning Transmission Electron Microscopy (STEM) and Energy Dispersive X-Ray Spectroscopy (EDS)
Particle sizes and core-shell structures of the uncoated and coated samples, as well as the chemical 
Computed Tomography (CT)
The anatomical contrast enhancement capability of α-Bi 2 O 3 NPs alone was demonstrated using CT.
Suspensions with concentrations of α-Bi 2 O 3 ranging from 0 to 20 mg/mL were placed in 1.5 mL vials.
The vials were imaged together using a Toshiba Asteion (model TSX-021A) whole body X-ray CT scanner with a 135 kV tube voltage, 200 mA tube current, 1 mm slice thickness and 93 mm field of view diameter. The CT images were obtained using the standard patient image reconstruction algorithms included with the scanner.
Cell Culture
Cellular experiments were carried out with GS-9L rat glioma cells derived from an N- 
The plating efficiency is the ratio of counted cell colonies (N) and initial seeding number (S):
Results and Discussion
Characterization of the Nanomaterials
In order to determine which phase of Bi 2 O 3 was synthesised and to investigate if the phase maintained single after coating with (3-aminopropyl)trimethoxysilane (APTMS) and further attachment of methotrexate (MTX), X-ray diffraction was used. FTIR spectroscopy was used to confirm that both APTMS and MTX were successfully immobilized on bismuth oxide NPs. Fig. 3(A) corresponds to aromatic C-C stretching (in ring). 30 The presence of C-N stretching vibrations which can be found in aromatic amines is confirmed by the band at 1325 cm The conjugate is still dispersed with an average size of 50 nm in diameter. 
Amount of Coated Silane and Attached MTX on α-Bi 2 O 3 Nanoparticles
The amount of coated silane on the surface of α-Bi 2 O 3 NPs was determined via EDS. The EDS spectra (Fig. S1) In addition, APTMS is cross-linked with each other, which lowers the concentration of free amine groups as well.
In Vitro CT Imaging
The aggregates, which will be the focus of future work.
Cellular Uptake and Cytotoxicity of the Nanomaterials
In order to be suitable as a theranostic system, the synthesised nanoparticle-drug conjugate needs to exhibit an increased cellular uptake which was examined by comparing the mean side-scattered light (SSC) of the control without additives (Fig. 6(A) of the former, while the reduced cellular uptake of the nanoparticle-drug conjugate can be attributed to the increase in particle size due to the attachment of MTX and associated hindered cellular entry. and 24 h exposure of (B) α-Bi2O3 NPs (c=50.00 µg/mL), (C) α-Bi2O3-APTMS NPs (c=53.48 µg/mL) and (D) the α-Bi2O3-APTMS-MTX conjugate (c=54.14 µg/mL).
The clonogenic assays of the tested treatments are illustrated in Fig. 7 and show cytotoxicity for α-Bi 2 O 3 (B) with a surviving fraction of 27±5%. The cytotoxicity can be explained by the high amount of oxygen with an atomic percentage of 52±3%, which was investigated via EDS, resulting in the generation of reactive oxygen species (ROS). 16 The MTX is a chemotherapeutic drug which can target cancer cells. In fact, a potential theranostic system was established which may improve the overall treatment procedure of cancer.
Conclusion
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